MET and cancer: The first of these mechanisms involves the binding and inactivation of JAK kinases including the TEL-JAK oncoprotein, receptor tyrosine kinases such the hepatocyte growth factor receptor MET implicated in the progression of diverse cancers, and signaling proteins with oncogenic potential such VAV and ONCOVAV [13,15,33].